Stay updated on Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial
Sign up to get notified when there's something new on the Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial page.

Latest updates to the Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial page
- Check3 days agoChange DetectedAdded Revision: v3.3.4 in the header and removed Revision: v3.3.3. The update is a minor UI/version-label change and does not affect core study content, eligibility criteria, outcomes, or location information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page’s Locations section was reorganized: CA, FL, MI, NV, and WA listings were added and removed as part of the update, and the page revision updated to v3.3.3.SummaryDifference0.4%

- Check53 days agoChange DetectedAdded PubMed auto-fill notice with revision v3.3.2 and removed the PubMed source description with revision v3.2.0; no core content changes were made. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedThe funding/operating-status notice on the page has been removed.SummaryDifference0.2%

- Check75 days agoChange Detected- IPD sharing plan now listed on the study page. - A Publications section with PubMed references (e.g., NEJM 2023; Haemophilia 2025) has been added to the study record.SummaryDifference0.3%

- Check103 days agoChange Detected- Added a government-funding notice about potential delays and updated operating status guidance, and a major version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference1%

Stay in the know with updates to Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial page.